Background: Reports have shown that microbial composition of individuals on antiretroviral therapy (ART) is different from that of non-HIV-infected individuals. However, the degree to which ART restores the microbial composition remains unclear. The aim of this study was to determine the effect of two types of ART regimens: Efavirenz-based regimen (EFV) and protease inhibitor-based regimen (PI) boosted with either Lopinavir (LPV/r) or Atazanavir (ATV/r) on fecal microbial diversity and composition.
Methods: All individuals gave informed consent. Fecal samples were obtained from 37 HIV-infected individuals: 20 on EFV-based regimen and 17 on a PI-based regimen and 9 non-HIV-infected individuals. The V3 region of the 16S rRNA gene was PCR amplified and sequenced on a semiconductor sequencer. Alpha diversity computation (observed species rarified at 49,208 sequences/sample), operational taxonomic unit (OTU) picking at 97% ID and taxonomy assignment was performed using QIIME 1.8.0. Statistical analysis was performed using two-tailed Mann-Whitney U-test (GraphPad Prism 6).
Results: Median CD4 counts were 457 cells/mm3 (235-1247) and 559 cells/mm3 (240-1177) for individuals on EFV- and PI-based regimen respectively (p=0.174). All individuals on ART had undetectable viral loads. Median duration of ART was 70 months ± SD 33.36. Individuals under EFV- had significantly lower diversity compared to those on PI-based regimen (p=0.0304) and to non-HIV-infected controls (p=0.0030). Microbial communities were profiled and four predominant phyla were found: Bacteroidetes, Firmicutes, Proteobacteria and Fusobacteria. The phylum Fusobacteria was only observed in individuals under EFV-based regimen (overall RA= 3.591% ± SD 9.05%). The relative abundance (RA) of Bacteroidetes was significantly reduced in individuals receiving EFV- as compared to those receiving PI-based regimen (p=0.0054) and to non-HIV-infected controls (p=0.0175). At the genus level, the RA of Prevotella was significantly reduced (p=0.0415) and the RA of Bacteroides was significantly enriched (p=0.0328) in individuals receiving EFV- compared to PI-based regimen.
Conclusions: Individuals on EFV-based regimen showed an alteration along the Prevotella/Bacteroides gradient, compared to those on a PI-based regimen. Further analyses are required to account for confounding factors. Deciphering the effects of different ARV regimens on gut microbiota composition is of great interest to develop therapies aimed at restoring the latter to a healthy state.